ELESTAT Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Elestat, and when can generic versions of Elestat launch?
Elestat is a drug marketed by Allergan and is included in one NDA.
The generic ingredient in ELESTAT is epinastine hydrochloride. There are six drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the epinastine hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Elestat
A generic version of ELESTAT was approved as epinastine hydrochloride by BRECKENRIDGE on March 14th, 2011.
Summary for ELESTAT
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 107 |
Clinical Trials: | 2 |
Patent Applications: | 422 |
Drug Prices: | Drug price information for ELESTAT |
What excipients (inactive ingredients) are in ELESTAT? | ELESTAT excipients list |
DailyMed Link: | ELESTAT at DailyMed |
Recent Clinical Trials for ELESTAT
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Aston University | Phase 4 |
University of Worcester | Phase 4 |
Merck Sharp & Dohme Corp. | Phase 4 |
Anatomical Therapeutic Chemical (ATC) Classes for ELESTAT
Paragraph IV (Patent) Challenges for ELESTAT
Tradename | Dosage | Ingredient | Strength | NDA | ANDAs Submitted | Submissiondate |
---|---|---|---|---|---|---|
ELESTAT | Ophthalmic Solution | epinastine hydrochloride | 0.05% | 021565 | 1 | 2008-10-14 |
US Patents and Regulatory Information for ELESTAT
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Allergan | ELESTAT | epinastine hydrochloride | SOLUTION/DROPS;OPHTHALMIC | 021565-001 | Oct 16, 2003 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for ELESTAT
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Allergan | ELESTAT | epinastine hydrochloride | SOLUTION/DROPS;OPHTHALMIC | 021565-001 | Oct 16, 2003 | ⤷ Try a Trial | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for ELESTAT
See the table below for patents covering ELESTAT around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Slovakia | 287343 | ⤷ Try a Trial | |
Slovakia | 8302002 | SOLUTIONS CONTAINING EPINASTINE | ⤷ Try a Trial |
Norway | 329417 | ⤷ Try a Trial | |
Portugal | 1231920 | ⤷ Try a Trial | |
>Country | >Patent Number | >Title | >Estimated Expiration |